Numares is an innovative diagnostics company. We focus on the discovery, development and commercialization of diagnostic tests, using metabolite constellations to solve unmet medical needs not addressed by single biomarker-based medicine.
Our diagnostic tests are based on the interpretation of biomarkers in the metabolism, whose dynamics and relation to each other allow for predicting disease progression. These metabolite constellations create diagnostics of a new generation: non-invasive, timely and meaningful at manageable costs.
FDA Submission of AXINON® GFR(NMR)